# MaxPax, LLC – FDA Inspection, Jul 25, 2019

Source: https://www.keypedia.com/records/fda_inspections/maxpax-llc/e39cb2d6-655c-425c-99c0-61a6006db1c2
Source feed: FDA_Inspections

> FDA inspection 1097437 of MaxPax, LLC, July 25, 2019. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1097437
- Company Name: MaxPax, LLC
- Inspection Date: 2019-07-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 6

## Related Documents

- [FDA Inspection 931181 - 2015-06-24](https://www.keypedia.com/records/fda_inspections/maxpax-llc/f2d62830-1c8f-46f0-b8e7-61a7eaa040fd)
- [FDA Inspection 885213 - 2014-07-11](https://www.keypedia.com/records/fda_inspections/maxpax-llc/427eab2f-7902-4cca-bb16-c74b90b1bef5)
- [FDA Inspection 814003 - 2013-01-14](https://www.keypedia.com/records/fda_inspections/maxpax-llc/c6a000ac-8614-439d-90ca-c2042abaeb4c)
- FDA Inspection 752375 - 2011-10-31
- FDA Inspection 604502 - 2009-08-14

## Related Officers

- [Company Rep](https://www.keypedia.com/people/ana-paula-p-sandee/7c96feb2-cb1d-4808-a65c-eafba38c3b2d)
- [FDA Associated Person](https://www.keypedia.com/people/michele-l-glendenning/a3c23a43-634c-4140-807b-c17fbc03bb00)

Company: https://www.keypedia.com/companies/maxpax-llc/e754fbaf-4ab2-48ec-8a53-1685761ffd3c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
